Literature DB >> 21172684

Neural plasticity and locomotor recovery after spinal cord injury.

Keith E Tansey1.   

Abstract

The discussion of neural plasticity and locomotor recovery after spinal cord injury (SCI) focuses on 2 main themes, the issues associated with detecting neural plasticity in human beings and the issue of how to translate information from animal models, in which neural plasticity can be more readily studied, to human clinical research and application. This article discusses the importance of studying neural plasticity to better understand the effects of current rehabilitation interventions and to devise the next generation of therapies. It reviews the current spectrum of clinical, functional, anatomical, and neurophysiological assessments of patients that can be made in neurorehabilitation and the relationship between those measures and the study of neural plasticity. Then the similarities and differences between animal models and human SCI are discussed in relation to the severity of injury, the effect of locomotor training on gait recovery, the localization of neural plasticity associated with that gait recovery, and the implications for interpreting the "translatability" of animal model data to human study and clinical practice. In summary, it is concluded that the study of neural plasticity and locomotor recovery after SCI is really in its infancy but that it is critical for the advancement of the science of neurorehabilitation and "restorative neurology."
Copyright © 2010 American Academy of Physical Medicine and Rehabilitation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21172684     DOI: 10.1016/j.pmrj.2010.10.007

Source DB:  PubMed          Journal:  PM R        ISSN: 1934-1482            Impact factor:   2.298


  9 in total

1.  Antispasmodic medications may be associated with reduced recovery during inpatient rehabilitation after traumatic spinal cord injury.

Authors:  Eric R Theriault; Vincent Huang; Gale Whiteneck; Marcel P Dijkers; Noam Y Harel
Journal:  J Spinal Cord Med       Date:  2016-11-14       Impact factor: 1.985

Review 2.  Rehabilitation Strategies after Spinal Cord Injury: Inquiry into the Mechanisms of Success and Failure.

Authors:  Marie-Pascale Côté; Marion Murray; Michel A Lemay
Journal:  J Neurotrauma       Date:  2016-11-21       Impact factor: 5.269

3.  Effects of body weight-support treadmill training on postural sway and gait independence in patients with chronic spinal cord injury.

Authors:  Felipe Covarrubias-Escudero; Gonzalo Rivera-Lillo; Rodrigo Torres-Castro; Gonzalo Varas-Díaz
Journal:  J Spinal Cord Med       Date:  2017-10-23       Impact factor: 1.985

Review 4.  Nervous system modulation through electrical stimulation in companion animals.

Authors:  Ângela Martins; Débora Gouveia; Ana Cardoso; Óscar Gamboa; Darryl Millis; António Ferreira
Journal:  Acta Vet Scand       Date:  2021-05-30       Impact factor: 1.695

Review 5.  Does repair of spinal cord injury follow the evolutionary theory?

Authors:  Zhicheng Zhang; Fang Li; Tiansheng Sun
Journal:  Neural Regen Res       Date:  2012-04-15       Impact factor: 5.135

Review 6.  The role of the serotonergic system in locomotor recovery after spinal cord injury.

Authors:  Mousumi Ghosh; Damien D Pearse
Journal:  Front Neural Circuits       Date:  2015-02-09       Impact factor: 3.492

7.  Effects of Remote Ischemic Conditioning on Hand Engagement in individuals with Spinal cord Injury (RICHES): protocol for a pilot crossover study.

Authors:  Yu-Kuang Wu; Noam Y Harel; Jill M Wecht; Ona E Bloom
Journal:  F1000Res       Date:  2021-06-10

8.  Soleus H and Lower Limb Posterior Root Muscle Reflexes During Stepping After Incomplete SCI.

Authors:  Keith E Tansey; Bradley J Farrell; Joy A Bruce; William B McKay
Journal:  Front Rehabil Sci       Date:  2022-05-13

Review 9.  The physiological basis of neurorehabilitation--locomotor training after spinal cord injury.

Authors:  Michèle Hubli; Volker Dietz
Journal:  J Neuroeng Rehabil       Date:  2013-01-21       Impact factor: 4.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.